← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

HSIC logoHenry Schein, Inc.(HSIC)Earnings, Financials & Key Ratios

HSIC•NASDAQ
$74.37
$8.53B mkt cap·22.7× P/E·Price updated May 6, 2026
SectorHealthcareIndustryMedical DistributionSub-IndustryDental and Office-Based Distribution
AboutHenry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.Show more
  • Revenue$13.18B+4.0%
  • EBITDA$1.07B+4.2%
  • Net Income$398M+2.1%
  • EPS (Diluted)3.27+7.2%
  • Gross Margin29.14%-1.9%
  • EBITDA Margin8.11%+0.2%
  • Operating Margin5.75%
  • Net Margin3.02%-1.9%
  • ROE8.27%+5.9%
  • ROIC7.15%
  • Debt/Equity0.77+29.6%
  • Interest Coverage4.63-5.8%
Technical→

HSIC Key Insights

Henry Schein, Inc. (HSIC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 4.7% through buybacks
  • ✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

HSIC Price & Volume

Henry Schein, Inc. (HSIC) stock price & volume — 10-year historical chart

Loading chart...

HSIC Growth Metrics

Henry Schein, Inc. (HSIC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.18%
5 Years5.43%
3 Years1.4%
TTM4.03%

Profit CAGR

10 Years-1.84%
5 Years-0.21%
3 Years-9.56%
TTM2.05%

EPS CAGR

10 Years1.38%
5 Years3.15%
3 Years-5.78%
TTM7.57%

Return on Capital

10 Years13.41%
5 Years11.79%
3 Years9.79%
Last Year9.84%

HSIC Recent Earnings

Henry Schein, Inc. (HSIC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 5, 2026
EPS
$1.32
Est $1.20
+10.0%
Revenue
$3.4B
Est $3.3B
+0.8%
Q1 2026
Feb 24, 2026
EPS
$1.34
Est $1.30
+3.1%
Revenue
$3.4B
Est $3.3B
+2.7%
Q4 2025
Nov 4, 2025
EPS
$1.38
Est $1.27
+8.7%
Revenue
$3.3B
Est $3.3B
-0.2%
Q3 2025
Aug 5, 2025
EPS
$1.10
Est $1.18
-6.8%
Revenue
$3.2B
Est $3.3B
-1.1%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$1.32vs $1.20+10.0%
$3.4Bvs $3.3B+0.8%
Q1 2026Feb 24, 2026
$1.34vs $1.30+3.1%
$3.4Bvs $3.3B+2.7%
Q4 2025Nov 4, 2025
$1.38vs $1.27+8.7%
$3.3Bvs $3.3B-0.2%
Q3 2025Aug 5, 2025
$1.10vs $1.18-6.8%
$3.2Bvs $3.3B-1.1%
Based on last 12 quarters of dataView full earnings history →

HSIC Peer Comparison

Henry Schein, Inc. (HSIC) competitors in Dental and Office-Based Distribution — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
DXPE logoDXPEDXP Enterprises, Inc.Direct Competitor2.78B179.2633.4411.89%4.4%17.79%1.94%0.17
OMI logoOMIOwens & Minor, Inc.Direct Competitor171.11M2.24-0.16-74.19%-39.85%-21.12%
MCK logoMCKMcKesson CorporationDirect Competitor98.11B801.0131.1416.22%1.09%5.33%
CAH logoCAHCardinal Health, Inc.Direct Competitor46.36B197.0030.54-1.87%0.62%3.99%
XRAY logoXRAYDENTSPLY SIRONA Inc.Product Competitor2.28B11.37-3.79-2.98%-17.06%-41.19%4.57%1.84
ALGN logoALGNAlign Technology, Inc.Product Competitor12.08B168.7129.860.9%10.5%10.7%4.06%0.03
NVST logoNVSTEnvista Holdings CorpProduct Competitor4.32B26.1993.548.32%0.58%0.5%5.33%0.51
PRTS logoPRTSCarParts.com, Inc.Product Competitor65.14M0.93-1.13-7.02%-9.21%-79.8%0.47

Compare HSIC vs Peers

Henry Schein, Inc. (HSIC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXPE

Most directly comparable listed peer for HSIC.

Scale Benchmark

vs SYK

Larger-name benchmark to compare HSIC against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXPE, OMI, MCK, CAH

HSIC Income Statement

Henry Schein, Inc. (HSIC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue12.46B13.2B9.99B10.12B12.4B12.65B12.34B12.67B13.18B
Revenue Growth %7.69%5.94%-24.36%1.34%22.55%1.98%-2.44%2.71%4.03%
Cost of Goods Sold9.06B6.51B6.89B7.3B8.73B9B8.69B8.91B9.34B
COGS % of Revenue72.72%49.29%69.05%72.19%70.39%71.15%70.41%70.29%70.86%
Gross Profit
3.4B▲ 0%
2.91B▼ 14.4%
3.09B▲ 6.2%
2.81B▼ 8.9%
3.67B▲ 30.5%
3.65B▼ 0.6%
3.65B▲ 0.1%
3.77B▲ 3.1%
3.84B▲ 2.0%
Gross Margin %27.28%22.05%30.95%27.81%29.61%28.85%29.59%29.71%29.14%
Gross Profit Growth %5.35%-14.37%6.19%-8.95%30.48%-0.63%0.05%3.12%2.05%
Operating Expenses2.53B2.22B2.36B2.25B2.82B2.71B2.94B3.04B3.08B
OpEx % of Revenue20.34%16.79%23.61%22.2%22.72%21.44%23.8%23.96%23.39%
Selling, General & Admin2.53B2.22B2.36B2.25B2.82B2.71B2.94B3.04B3.08B
SG&A % of Revenue20.34%16.79%23.61%22.2%22.72%21.44%23.8%23.96%23.39%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses000000000
Operating Income
864.69M▲ 0%
693.47M▼ 19.8%
732.97M▲ 5.7%
567.4M▼ 22.6%
854.81M▲ 50.7%
938M▲ 9.7%
714M▼ 23.9%
729M▲ 2.1%
758M▲ 4.0%
Operating Margin %6.94%5.25%7.34%5.61%6.89%7.42%5.79%5.75%5.75%
Operating Income Growth %5.78%-19.8%5.69%-22.59%50.65%9.73%-23.88%2.1%3.98%
EBITDA1.06B837.1M917.91M752.93M1.06B1.15B962M1.03B1.07B
EBITDA Margin %8.49%6.34%9.19%7.44%8.58%9.09%7.8%8.1%8.11%
EBITDA Growth %7.14%-20.86%9.65%-17.97%41.36%8.05%-16.35%6.65%4.19%
D&A (Non-Cash Add-back)193.07M143.63M184.94M185.54M209.53M212M248M297M311M
EBIT876.5M612.85M731.1M541.27M858.15M765M629M644M695M
Net Interest Income-36.1M-60.52M-35.03M-31.54M-21.15M-27M-70M-107M-117M
Interest Income17.55M15.49M15.76M9.84M6.45M17M17M24M33M
Interest Expense53.65M76.02M50.79M41.38M27.6M44M87M131M150M
Other Income/Expense-42.9M-135.6M-34.76M-55.16M-4.25M-202M-158M-203M-213M
Pretax Income
821.8M▲ 0%
557.87M▼ 32.1%
698.21M▲ 25.2%
512.24M▼ 26.6%
850.56M▲ 66.0%
736M▼ 13.5%
556M▼ 24.5%
526M▼ 5.4%
545M▲ 3.6%
Pretax Margin %6.59%4.23%6.99%5.06%6.86%5.82%4.51%4.15%4.13%
Income Tax362.51M107.43M159.51M95.37M197.35M170M120M128M126M
Effective Tax Rate %44.11%19.26%22.85%18.62%23.2%23.1%21.58%24.33%23.12%
Net Income
406.3M▲ 0%
535.88M▲ 31.9%
507.96M▼ 5.2%
402.22M▼ 20.8%
623.91M▲ 55.1%
538M▼ 13.8%
416M▼ 22.7%
390M▼ 6.3%
398M▲ 2.1%
Net Margin %3.26%4.06%5.09%3.97%5.03%4.25%3.37%3.08%3.02%
Net Income Growth %-19.83%31.89%-5.21%-20.82%55.12%-13.77%-22.68%-6.25%2.05%
Net Income (Continuing)459.29M450.44M538.69M416.87M653.21M566M436M398M419M
Discontinued Operations0105.16M-5.96M986K00000
Minority Interest845.05M892.61M919.35M963.91M1.25B1.23B1.5B1.44B1.55B
EPS (Diluted)
2.57▲ 0%
3.49▲ 35.8%
3.40▼ 2.6%
2.80▼ 17.6%
4.45▲ 58.9%
3.91▼ 12.1%
3.16▼ 19.2%
3.05▼ 3.5%
3.27▲ 7.2%
EPS Growth %-17.63%35.8%-2.58%-17.65%58.93%-12.13%-19.18%-3.48%7.21%
EPS (Basic)2.593.513.442.824.513.953.183.073.29
Diluted Shares Outstanding158.21M153.71M149.26M143.4M141.77M137.76M131.75M127.78M121.72M
Basic Shares Outstanding156.79M152.66M147.82M142.5M140.09M136.06M130.62M126.79M120.81M
Dividend Payout Ratio---------

HSIC Balance Sheet

Henry Schein, Inc. (HSIC) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets4.09B4.18B3.23B3.79B3.84B3.99B4.49B3.98B4.46B
Cash & Short-Term Investments174.66M56.88M106.1M421.19M118M117M171M122M156M
Cash Only174.66M56.88M106.1M421.19M118M117M171M122M156M
Short-Term Investments000000000
Accounts Receivable1.52B1.17B1.25B1.42B1.45B1.44B1.86B1.48B1.65B
Days Sales Outstanding44.632.3145.5551.3942.7441.6255.1142.6845.71
Inventory1.93B1.42B1.43B1.51B1.86B1.96B1.81B1.81B2B
Days Inventory Outstanding77.8979.475.6475.5877.8279.6376.2574.1678.22
Other Current Assets01.08B00-103K466M639M569M655M
Total Non-Current Assets3.78B4.33B3.92B3.98B4.64B4.62B6.08B6.24B6.75B
Property, Plant & Equipment375M314.22M561.31M630.85M691M667M823M824M922M
Fixed Asset Turnover33.23x42.01x17.79x16.04x17.95x18.96x14.99x15.38x14.30x
Goodwill2.3B2.08B2.46B2.5B2.85B2.89B3.88B3.89B4.21B
Intangible Assets671.02M376.61M572.88M479.43M668M587M916M1.02B1.02B
Long-Term Investments268.36M260.95M164.66M169.38M168M161M180M170M0
Other Non-Current Assets151.3M1.28B139.63M154.47M221M223M253M284M598M
Total Assets
7.86B▲ 0%
8.5B▲ 8.1%
7.15B▼ 15.9%
7.77B▲ 8.7%
8.48B▲ 9.1%
8.61B▲ 1.5%
10.57B▲ 22.8%
10.22B▼ 3.4%
11.21B▲ 9.8%
Asset Turnover1.58x1.55x1.40x1.30x1.46x1.47x1.17x1.24x1.18x
Asset Growth %16.32%8.09%-15.87%8.69%9.12%1.49%22.84%-3.36%9.76%
Total Current Liabilities2.83B3.22B2.04B2.28B2.31B2.22B2.68B2.8B3.23B
Accounts Payable1.15B785.76M880.27M1.01B1.05B1B1.02B962M1.15B
Days Payables Outstanding46.4444.0846.650.2544.0740.7342.8539.4245.09
Short-Term Debt758.31M959.74M133.82M183.2M62M109M414M706M875M
Deferred Revenue (Current)000000000
Other Current Liabilities0577.61M000000680M
Current Ratio1.44x1.30x1.58x1.66x1.67x1.79x1.67x1.42x1.38x
Quick Ratio0.76x0.86x0.88x1.00x0.86x0.91x1.00x0.78x0.76x
Cash Conversion Cycle76.0567.6474.5976.7276.4880.5288.5177.4378.84
Total Non-Current Liabilities1.38B1.43B1.2B1.18B1.5B1.71B2.74B2.58B3.19B
Long-Term Debt907.76M980.34M622.91M515.77M811M1.04B1.94B1.83B2.56B
Capital Lease Obligations00176.27M238.73M268M275M310M259M251M
Deferred Tax Liabilities50.43M27.22M64.99M30.07M42M36M54M102M146M
Other Non-Current Liabilities420.29M420.19M331.17M392.78M377M361M436M379M235M
Total Liabilities4.21B4.65B3.23B3.46B3.81B3.94B5.42B5.38B6.42B
Total Debt1.67B1.94B998.35M1B1.22B1.5B2.74B2.87B3.69B
Net Debt1.49B1.88B892.25M581.23M1.1B1.38B2.57B2.75B3.53B
Debt / Equity0.46x0.50x0.25x0.23x0.26x0.32x0.53x0.59x0.77x
Debt / EBITDA1.58x2.32x1.09x1.33x1.14x1.30x2.85x2.80x3.45x
Net Debt / EBITDA1.41x2.25x0.97x0.77x1.03x1.20x2.67x2.68x3.30x
Interest Coverage16.34x8.06x14.39x13.08x31.09x17.39x7.23x4.92x4.63x
Total Equity
3.66B▲ 0%
3.85B▲ 5.4%
3.92B▲ 1.6%
4.31B▲ 10.1%
4.68B▲ 8.4%
4.67B▼ 0.1%
5.15B▲ 10.3%
4.84B▼ 6.1%
4.79B▼ 0.9%
Equity Growth %7.28%5.4%1.65%10.08%8.44%-0.11%10.32%-6.13%-0.89%
Book Value per Share23.1125.0726.2530.0732.9833.9139.1137.8539.39
Total Shareholders' Equity2.81B2.96B3B3.35B3.42B3.45B3.65B3.39B3.25B
Common Stock1.54M1.51M1.43M1.43M1M1M1M1M1M
Retained Earnings2.94B3.21B3.12B3.45B3.6B3.68B3.86B3.77B3.29B
Treasury Stock000000000
Accumulated OCI-130.07M-248.77M-167.37M-108.08M-171M-233M-206M-379M-226M
Minority Interest845.05M892.61M919.35M963.91M1.25B1.23B1.5B1.44B1.55B

HSIC Cash Flow Statement

Henry Schein, Inc. (HSIC) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations545.51M684.71M654.09M599M709.58M602M500M848M712M
Operating CF Margin %4.38%5.19%6.55%5.92%5.72%4.76%4.05%6.69%5.4%
Operating CF Growth %-11.36%25.52%-4.47%-8.42%18.46%-15.16%-16.94%69.6%-16.04%
Net Income459.29M562.13M719.14M404M660.53M566M416M398M398M
Depreciation & Amortization193.07M207.56M184.94M186M209.53M212M222M268M311M
Stock-Based Compensation42.29M36.24M44.92M9M78M54M39M39M0
Deferred Taxes138.17M-51.86M-2.12M0-12.93M-61M0-56M5M
Other Non-Cash Items44.5M13.34M-338.37M227M-28.34M112M57M59M46M
Working Capital Changes-331.81M-82.7M45.57M-227M-197.2M-281M-234M140M-48M
Change in Receivables-159.88M-147.5M-72.69M-189M4.16M-7M-327M315M-124M
Change in Inventory-175.06M-84.78M14.7M-32M-295.13M-126M231M-59M-95M
Change in Payables89.28M241.65M160.85M084.71M-96M0-163M216M
Cash from Investing-342.28M-192.95M-424.37M-115M-677.22M-276M-1.14B-430M-477M
Capital Expenditures-81.5M-90.64M-76.22M-49M-79.02M-96M-147M-148M-191M
CapEx % of Revenue0.65%0.69%0.76%0.48%0.64%0.76%1.19%1.17%1.45%
Acquisitions-254.63M-60.57M-348.63M-52M-560.8M-158M0-230M-276M
Investments---------
Other Investing248.47M18.82M349.1M-14M-37.4M-22M-988M-56M-10M
Cash from Financing-112.55M-603.78M-215.98M-187M-332.96M-315M701M-510M-111M
Debt Issued (Net)141.15M90.27M-1.19B-110M165M259M900M189M551M
Equity Issued (Net)-494.83M-218.02M-163.91M-88M-409M-517M-284M-385M-598M
Dividends Paid000000000
Share Repurchases-450M-200M-525M-88M-401M-485M-284M-385M-850M
Other Financing241.13M-476.02M1.14B11M-88.96M-57M85M-314M-64M
Net Change in Cash
112.28M▲ 0%
-94.45M▼ 184.1%
49.21M▲ 152.1%
314.9M▲ 539.9%
-303.22M▼ 196.3%
-1M▲ 99.7%
54M▲ 5500.0%
-49M▼ 190.7%
34M▲ 169.4%
Free Cash Flow
464.01M▲ 0%
594.07M▲ 28.0%
577.87M▼ 2.7%
550M▼ 4.8%
630.57M▲ 14.6%
506M▼ 19.8%
353M▼ 30.2%
661M▲ 87.3%
573M▼ 13.3%
FCF Margin %3.72%4.5%5.79%5.44%5.08%4%2.86%5.22%4.35%
FCF Growth %-14.9%28.03%-2.73%-4.82%14.65%-19.75%-30.24%87.25%-13.31%
FCF per Share2.933.863.873.844.453.672.685.174.71
FCF Conversion (FCF/Net Income)1.34x1.28x1.29x1.49x1.14x1.12x1.20x2.17x1.79x
Interest Paid00043M29M47M84M132M0
Taxes Paid0000242M265M0144M0

HSIC Key Ratios

Henry Schein, Inc. (HSIC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)14.82%11.5%14.27%13.07%9.78%13.88%11.51%8.47%7.81%8.27%
Return on Invested Capital (ROIC)14.04%13.35%9.56%10.42%8.77%12.02%11.9%7.78%7.14%7.15%
Gross Margin27.88%27.28%22.05%30.95%27.81%29.61%28.85%29.59%29.71%29.14%
Net Margin4.38%3.26%4.06%5.09%3.97%5.03%4.25%3.37%3.08%3.02%
Debt / Equity0.36x0.46x0.50x0.25x0.23x0.26x0.32x0.53x0.59x0.77x
Interest Coverage24.70x16.34x8.06x14.39x13.08x31.09x17.39x7.23x4.92x4.63x
FCF Conversion1.21x1.34x1.28x1.29x1.49x1.14x1.12x1.20x2.17x1.79x
Revenue Growth8.86%7.69%5.94%-24.36%1.34%22.55%1.98%-2.44%2.71%4.03%

HSIC SEC Filings & Documents

Henry Schein, Inc. (HSIC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 24, 2026·SEC

Material company update

Jan 12, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 25, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 5, 2025·SEC

HSIC Frequently Asked Questions

Henry Schein, Inc. (HSIC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Henry Schein, Inc. (HSIC) reported $13.18B in revenue for fiscal year 2025. This represents a 1488% increase from $830.0M in 1996.

Henry Schein, Inc. (HSIC) grew revenue by 4.0% over the past year. Growth has been modest.

Yes, Henry Schein, Inc. (HSIC) is profitable, generating $398.0M in net income for fiscal year 2025 (3.0% net margin).

Dividend & Returns

Henry Schein, Inc. (HSIC) has a return on equity (ROE) of 8.3%. This is below average, suggesting room for improvement.

Henry Schein, Inc. (HSIC) generated $561.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More HSIC

Henry Schein, Inc. (HSIC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.